PURE Bioscience, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
Asset Breakdown FY2021
Total Assets: $4.3M
Liabilities Breakdown FY2021
Total Liabilities: $970.0K
Asset Breakdown
Total Assets: $4.3M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $2.4M | 55.5% |
| Accounts Receivable | $368.0K | 8.6% |
| Inventory | $332.0K | 7.7% |
| Property, Plant & Equipment | $740.0K | 17.2% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $366.0K | 8.5% |
| Other Assets | $107.0K | 2.5% |
Liabilities Breakdown
Total Liabilities: $970.0K
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $593.0K | 61.1% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $377.0K | 38.9% |